Whole exome sequencing and genetic association of gemcitabine/carboplatin induced thrombocytopenia in non-small cell lung cancer patients

被引：0
|
作者：
Bjorn, Niclas
Svedberg, Anna
Sigurgeirsson, Benjamin
Pradhananga, Sailendra
Branden, Eva
Koyi, Hirsh
Lewensohn, Rolf
De Petris, Luigi
Rodriguez-Antona, Cristina
Apellaniz-Ruiz, Maria
Lundeberg, Joakim
Green, Henrik
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5028
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing
    Svedberg, Anna
    Bjorn, Niclas
    Sigurgeirsson, Benjamin
    Pradhananga, Sailendra
    Branden, Eva
    Koyi, Hirsh
    Lewensohn, Rolf
    De Petris, Luigi
    Apellaniz-Ruiz, Maria
    Rodriguez-Antona, Cristina
    Lundeberg, Joakim
    Green, Henrik
    LUNG CANCER, 2020, 147 : 106 - 114
  • [2] Association to drug-induced leukopenia using whole-exome sequencing of non-small cell lung cancer patients on gemcitabine/carboplatin regimen
    Svedberg, Anna
    Sigurgeirsson, Benjamin
    Bjorn, Niclas
    Pradhananga, Sailendra
    Branden, Eva
    Koyi, Hirsh
    Lewensohn, Rolf
    De Petris, Luigi
    Rodriguez-Antona, Cristina
    Apellaniz-Ruiz, Maria
    Lundeberg, Joakim
    Green, Henrik
    CANCER RESEARCH, 2017, 77
  • [3] Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer
    Dómine, M
    Casado, V
    Estévez, LG
    León, A
    Martin, JI
    Castillo, M
    Rubio, G
    Lobo, F
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 4 - 9
  • [4] Whole-exome sequencing of Brazilian non-small cell lung cancer
    Leal, Leticia Ferro
    Evangelista, Adriane Feijo
    de Marchi, Pedro R.
    Camargo Rodrigues, Ysadhora Christiane
    Albino da Silva, Eduardo Caetano
    Reis, Rui Manuel
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients
    Bjorn, Niclas
    Badam, Tejaswi Venkata Satya
    Spalinskas, Rapolas
    Branden, Eva
    Koyi, Hirsh
    Lewensohn, Rolf
    De Petris, Luigi
    Lubovac-Pilav, Zelmina
    Sahlen, Pelin
    Lundeberg, Joakim
    Gustafsson, Mika
    Green, Henrik
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2020, 6 (01)
  • [6] Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients
    Niclas Björn
    Tejaswi Venkata Satya Badam
    Rapolas Spalinskas
    Eva Brandén
    Hirsh Koyi
    Rolf Lewensohn
    Luigi De Petris
    Zelmina Lubovac-Pilav
    Pelin Sahlén
    Joakim Lundeberg
    Mika Gustafsson
    Henrik Gréen
    npj Systems Biology and Applications, 6
  • [7] Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Zatloukal, P
    Petruzelka, L
    LUNG CANCER, 2002, 38 : S33 - S36
  • [8] Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Park, SH
    Jeong, SH
    Kyung, SY
    Lim, YH
    An, CH
    Lee, SP
    Park, JW
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    MEDICAL ONCOLOGY, 2005, 22 (04) : 359 - 366
  • [9] Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer
    Harper, P
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 2 - 12
  • [10] Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?
    Saha, Antonio
    Rudd, Robin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (02) : 165 - 173
12345